Contraceptive Options for Women and Couples with HIV

  • Slides: 23
Download presentation
Contraceptive Options for Women and Couples with HIV Combined Oral Contraceptive Pills (COCs)

Contraceptive Options for Women and Couples with HIV Combined Oral Contraceptive Pills (COCs)

Types of COCs Content Combination of two hormones: estrogen and progestin Phasic Monophasic, biphasic,

Types of COCs Content Combination of two hormones: estrogen and progestin Phasic Monophasic, biphasic, triphasic Dose Low-dose (most common): 30 -35 µg of estrogen or less High-dose: 50 µg of estrogen Pills per pack 21: all active (7 days break between packs) 28: 21 active + 7 inactive pills (no break between packs)

Effectiveness Spermicides Female condom Standard Days Method Male condom Oral contraceptives DMPA IUD (TCu-380

Effectiveness Spermicides Female condom Standard Days Method Male condom Oral contraceptives DMPA IUD (TCu-380 A) Rate during perfect use Female sterilization Rate during typical use Implants 0 5 10 15 20 25 30 Percentage of women pregnant in first year of use Source: CCP and WHO, 2007.

COCs – Mechanism of Action • Primary mechanism: suppression of ovulation • Other mechanism:

COCs – Mechanism of Action • Primary mechanism: suppression of ovulation • Other mechanism: fertilization prevention – thickened cervical mucus makes it difficult for sperm to enter uterus and unite with egg COCs have no effect on an existing pregnancy.

COCs – Characteristics Advantages Disadvantages • Safe and more than 99% effective if used

COCs – Characteristics Advantages Disadvantages • Safe and more than 99% effective if used correctly • Not as effective in typical use (92%) • Reversible • Require daily uptake • Protection from symptomatic PID • No STI/HIV protection • Non-contraceptive health benefits • Common side effects (serious complications rare)

COCs – Common Side Effects Bleeding Non-menstrual • Breakthrough light • Nausea bleeding and

COCs – Common Side Effects Bleeding Non-menstrual • Breakthrough light • Nausea bleeding and • Weight change spotting • Dizziness • Amenorrhea • Mild headaches • Breast tenderness • Mood changes Side effects are not experienced by all users. They are not harmful but may be unpleasant. Source: Ory, 1982; CCP and WHO, 2007.

Non-contraceptive Health Benefits of COCs: Overview Reduced risk of: • Ovarian and endometrial cancer

Non-contraceptive Health Benefits of COCs: Overview Reduced risk of: • Ovarian and endometrial cancer • Functional ovarian cysts • Ectopic pregnancy • Symptomatic PID Source: CCP and WHO, 2007. Improvement of: • Menstrual problems • Some gynecologic conditions

Non-contraceptive Health Benefits of COCs: Menstrual and Other Improvements • Decreased amount of flow

Non-contraceptive Health Benefits of COCs: Menstrual and Other Improvements • Decreased amount of flow and days of bleeding • Reduced risk of anemia • Decreased symptoms of dysmenorrhea • Decreased symptoms of endometriosis • Reduced symptoms of premenstrual syndrome Source: Belsey, 1988; Davis, 2005; Davis, 2007.

Adverse Effects of COCs: Overview • Severe adverse effects rare • Slight increase in

Adverse Effects of COCs: Overview • Severe adverse effects rare • Slight increase in risk concentrated among a subgroup of women with particular characteristics • Some effects immediate, some long term

Adverse Effects of COCs: Cardiovascular Disease (CVD) • COCs may slightly increase risk of

Adverse Effects of COCs: Cardiovascular Disease (CVD) • COCs may slightly increase risk of heart attack, stroke, and thromboembolism – lower estrogen dose in newer pills make CVD risk minimal – women who develop CVD have other risk factors (e. g. smoking, hypertension, diabetes) • In rare event CVD conditions develop: – they begin soon after initiation – pills must be discontinued Source: WHO, 1998.

Adverse Effects of COCs: Breast Cancer • No overall increase in breast cancer risk

Adverse Effects of COCs: Breast Cancer • No overall increase in breast cancer risk among women who had ever used COCs • Very slight risk increase in current COC users and within 10 years after discontinuation – may be due to accelerated growth of already existing tumors • Absolute number of breast cancer cases attributable to COCs is very small Source: WHO Collaborative Study of Neoplasia and Steroid Contraceptives, 1989; Collaborative Group on Hormonal Factors in Breast Cancer, 1996.

Adverse Effects of COCs: Cervical and Liver Cancer Cervical cancer • Small increase in

Adverse Effects of COCs: Cervical and Liver Cancer Cervical cancer • Small increase in risk among COC users – other factors may play a role – association is not clear Liver cancer • Countries with low incidence – no increased risk • Countries with high incidence – small increase among COC users Source: WHO Collaborative Study of Neoplasia and Steroid Contraceptives, 1985 and 1989.

Category 1 and 2 Examples (not inclusive): Who Can Use COCs WHO Category Conditions

Category 1 and 2 Examples (not inclusive): Who Can Use COCs WHO Category Conditions Category 1 menarche to 39 years; endometriosis; endometrial or ovarian cancer; uterine fibroids; family history of breast cancer; varicose veins; irregular, heavy, or prolonged bleeding; anemia; STI/PID; hepatitis (chronic/carrier) Category 2 ≥ 40 years; breastfeeding ≥ 6 months postpartum; superficial thrombophlebitis; uncomplicated diabetes; cervical cancer; unexplained vaginal bleeding; undiagnosed breast mass Source: WHO, 2004; updated 2008.

Category 3 and 4 Examples (not inclusive): Who Should Not Use COCs WHO Category

Category 3 and 4 Examples (not inclusive): Who Should Not Use COCs WHO Category Conditions Category 3 breastfeeding between 6 weeks and 6 months postpartum; non-breastfeeding <21 days postpartum; hypertension (140 -159/90– 99); migraine without aura (<35 years/continue use); gall bladder disease; use of rifampicin, rifabutin Category 4 breastfeeding <6 weeks postpartum, hypertension (≥ 160/≥ 100), migraines with aura, deep venous thrombosis (history or acute), ischemic heart disease or stroke, complicated diabetes, breast cancer, acute/flare hepatitis, severe liver disease and most liver tumors Source: WHO, 2004; updated 2008.

COC Use by Women with HIV WHO Eligibility Criteria Condition Category • Women with

COC Use by Women with HIV WHO Eligibility Criteria Condition Category • Women with HIV or AIDS can use without restrictions • Women on ARVs other than ritonavir can use COCs safely HIV-infected 1 AIDS 1 • Should not be used by women who take ritonavir 2 • Using low-dose COCs is appropriate ARV therapy (which does not contain ritonavir) Ritonavir/ ritonavirboosted PIs 3 (as part of ARV regimen) Source: WHO, 2004, updated 2008; Sekar, 2008. • Dual method use should be encouraged

How to Take COCs: When to Initiate • Anytime provider is reasonably sure woman

How to Take COCs: When to Initiate • Anytime provider is reasonably sure woman is not pregnant • First 5 days of menstrual cycle • After 5 th day, use backup method for 7 days • Postpartum: – not breastfeeding: delay 3 weeks – breastfeeding: delay 6 months or until breastfeeding is discontinued Source: WHO, 2004; updated 2008.

How to Take COCs: Schedule and Missed Pills Schedule: • Take one pill every

How to Take COCs: Schedule and Missed Pills Schedule: • Take one pill every day • 21 -day packs 7 -day break • 28 -day packs no break between packs Missed pill: Missed 1 or 2 active pills in a row Source: WHO, 2004; updated 2008. • Take missed pill as soon as remembered • Keep taking other pills on schedule • No backup method needed

How to Take COCs: Missed Pills • Take first missed pill as soon as

How to Take COCs: Missed Pills • Take first missed pill as soon as you remember • Continue daily pill taking as usual and use backup method or abstain for next 7 days • Count number of active pills remaining in pack Miss 3 or more active pills in a row or start pack 3 or more days late 7 or more active pills left in the pack Fewer than 7 active pills left in the pack • Finish active pills • Take hormone-free break • Finish active pills • Discard inactive pills • Start new pack immediately Source: WHO, 2004; updated 2008.

Management of COC Side Effects: Non-Menstrual Problems Problem Action/Management Any client concerns Provide counseling

Management of COC Side Effects: Non-Menstrual Problems Problem Action/Management Any client concerns Provide counseling Dizziness, nausea Reassure client: usually diminish over time Nausea and vomiting Take pills with food or at bedtime Weight change Counsel about healthy eating habits and Source: CCP and WHO, 2007. exercise If side effects persist and are unacceptable to client: if possible, switch pill formulation or switch to another method

Management of COC Side Effects: Bleeding Problems Problem Action/Management Unexplained Assess cause (consider vaginal

Management of COC Side Effects: Bleeding Problems Problem Action/Management Unexplained Assess cause (consider vaginal bleeding pregnancy or disease) or amenorrhea Breakthrough bleeding Reassure client: reinforce correct pill taking Prolonged bleeding Administer non-steroidal anti-inflammatory Use pills with more potent progestin (if available) Amenorrhea Reassure client: no medical treatment necessary Source: CCP and WHO, 2007. Action based on assessment If side effects persist and are unacceptable to client: switch to another method

Key Counseling Topics for COC Users • Safety and efficacy (depends on woman’s ability

Key Counseling Topics for COC Users • Safety and efficacy (depends on woman’s ability to take pills on time) • How COCs work • Possible side effects • How to take pills; what to do if pills are missed • No protection from STIs/HIV • When to return

When to Return: Warning Signs of COC Complications Return immediately if experiencing ACHES: •

When to Return: Warning Signs of COC Complications Return immediately if experiencing ACHES: • Abdominal pain (sharp) • Chest pain (severe) • Headache (severe) • Eye (blurred vision, brief loss of vision) • Sharp leg pain Advise to stop taking pills, use a backup method, and return to the clinic immediately. Source: Pathfinder International, 2006.

When to Return: Follow-up for COCs • No fixed schedule • Return anytime if

When to Return: Follow-up for COCs • No fixed schedule • Return anytime if any questions or concerns and for resupply; give more than one cycle of pills if possible • During follow-up visit: – assess for method satisfaction and any health problems that may restrict COC use – manage and reassure about side effects – reinforce correct pill taking and what to do when pills are missed